Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complete Pathological Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02511847
What this trial is testing

Trial of Afatinib With Paclitaxel for Neoadjuvant Therapy of TNBC and Research of Biomarkers of Afatinib

Who this might be right for
Triple Negative Breast Cancer
National Taiwan University Hospital 40
Testing effectiveness (Phase 2)UnknownNCT01520558
What this trial is testing

CNDO-109-AANK for AML in First Complete Remission (CR1)

Who this might be right for
Acute Myeloid Leukemia
Coronado Biosciences, Inc. 12
Not applicableUnknownNCT04917263
What this trial is testing

IMMUNOlogical Microenvironment in REctal Adenocarcinoma Treatment.

Who this might be right for
Rectal Cancer
University of Padova 544
Not applicableLooking for participantsNCT07430579
What this trial is testing

Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma

Who this might be right for
Pathological Complete RemissionObjective Response RateImmune-related Adverse Events+1 more
The Second Hospital of Shandong University 25
Large-scale testing (Phase 3)UnknownNCT02937012
What this trial is testing

Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders

Who this might be right for
Primary Biliary Cirrhosis
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 34
Large-scale testing (Phase 3)Ended earlyNCT00362466
What this trial is testing

Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy

Who this might be right for
Leukemia
Bristol-Myers Squibb 3
Testing effectiveness (Phase 2)Study completedNCT00093639
What this trial is testing

Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate

Who this might be right for
Leukemia
Novartis Pharmaceuticals
Not applicableStudy completedNCT00109525
What this trial is testing

Early Diagnosis of Candidiasis in Premature Infants

Who this might be right for
InfectionCandidaCandidiasis+4 more
NICHD Neonatal Research Network 1,500
Not applicableUnknownNCT04278274
What this trial is testing

Post-Neoadjuvant Treatment MRI Based AI System to Predict pCR for Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 205
Not applicableStudy completedNCT01316250
What this trial is testing

Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
American University of Beirut Medical Center 13
Testing effectiveness (Phase 2)Study completedNCT00466726
What this trial is testing

Vaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 57
Testing effectiveness (Phase 2)UnknownNCT01887561
What this trial is testing

Dasatinib for Patients Achieving Complete Molecular Response for Cure D-NewS Trial

Who this might be right for
Myelogenous Leukemia, Chronic, Chronic Phase
Kanto CML Study Group 100
Testing effectiveness (Phase 2)Looking for participantsNCT05918328
What this trial is testing

Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Henan Cancer Hospital 610
Early research (Phase 1)Study completedNCT00233961
What this trial is testing

G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission

Who this might be right for
Leukemia
Herbert Irving Comprehensive Cancer Center 20
Not applicableStudy completedNCT05931042
What this trial is testing

Neoadjuvant Therapy With Trastuzumab and Chemotherapy and the Resultant Pathologic Complete Response Observed in HER2 Positive Breast Cancer;a Systematic Review

Who this might be right for
HER2+ Breast Cancer
Rawalpindi Medical College 1,209
Testing effectiveness (Phase 2)Study completedNCT02789254
What this trial is testing

FLYSYN in MRD Positive AML

Who this might be right for
Acute Myeloid Leukemia
Synimmune GmbH 31
Not applicableUnknownNCT06250829
What this trial is testing

Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IB (Resectable)Non-small Cell Lung Cancer Stage II (Resectable)Non-small Cell Lung Cancer Stage ⅢA (Resectable)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60
Testing effectiveness (Phase 2)UnknownNCT01340508
What this trial is testing

Preoperative Concurrent Chemotherapy and Intensity Modulated Radiotherapy (IMRT) in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancers.
National University Hospital, Singapore 63
Testing effectiveness (Phase 2)Study completedNCT01203267
What this trial is testing

Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer

Who this might be right for
Breast Cancer
Shanghai Jiao Tong University School of Medicine 108
Testing effectiveness (Phase 2)Looking for participantsNCT06831955
What this trial is testing

LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer (TNBC), Early Setting
Universitaire Ziekenhuizen KU Leuven 356
Next Page